Development of Novel CREB1-PROTACs for Enhanced Targeting of CREB1 in Multiple Myeloma
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03755-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
Johnathan Altom is an academic researcher from The Ohio State University. The author has contributed to research in topics: Protein Degradation and Inhibitors & Autophagy in Disease and Therapy & Multiple Myeloma Research and Treatments.
https://doi.org/10.1016/s2152-2650(25)03755-3
https://doi.org/10.1038/s41419-025-08246-z
Click to start Chat